Literature DB >> 18937430

Large changes in the CRAC segment of gp41 of HIV do not destroy fusion activity if the segment interacts with cholesterol.

Sundaram A Vishwanathan1, Annick Thomas, Robert Brasseur, Raquel F Epand, Eric Hunter, Richard M Epand.   

Abstract

The membrane-proximal external region (MPER) of the gp41 fusion protein of HIV is highly conserved among isolates of this virus and is considered a target for vaccine development. This region also appears to play a role in membrane fusion as well as localization of the virus to cholesterol-rich domains in membranes. The carboxyl terminus of MPER has the sequence LWYIK and appears to have an important role in cholesterol interactions. We have tested how amino acid substitutions that would affect the conformational flexibility of this segment could alter its interaction with cholesterol. We studied a family of peptides (all peptides as N-acetyl-peptide amides) with P, G, or A substituting for W and I of the LWYIK sequence. The peptide having the greatest effect on cholesterol distribution in membranes was the most flexible one, LGYGK. The corresponding mutation in gp41 resulted in a protein retaining 72% of the fusion activity of the wild-type protein. Two other peptides were synthesized, also containing two Gly residues, GWGIK and LWGIG, and did not have the ability to sequester cholesterol as efficiently as LGYGK did. Making the corresponding mutants of gp41 showed that these other two double Gly substitutions resulted in proteins that were much less fusogenic, although they were equally well expressed at the cell surface. The study demonstrates that drastic changes can be made in the LWYIK segment with the retention of a significant fraction of the fusogenic activity, as long as the mutant proteins interact with cholesterol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18937430      PMCID: PMC2667962          DOI: 10.1021/bi8014828

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  38 in total

1.  Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.

Authors:  T Suárez; W R Gallaher; A Agirre; F M Goñi; J L Nieva
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Cholesterol crystalline polymorphism and the solubility of cholesterol in phosphatidylserine.

Authors:  R M Epand; D Bach; N Borochov; E Wachtel
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

3.  Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.

Authors:  Antony S Dimitrov; Satinder S Rawat; Shibo Jiang; Robert Blumenthal
Journal:  Biochemistry       Date:  2003-12-09       Impact factor: 3.162

4.  Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups.

Authors:  Nadine Vincent; Christian Genin; Etienne Malvoisin
Journal:  Biochim Biophys Acta       Date:  2002-12-23

5.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring.

Authors:  Asier Sáez-Cirión; Shlomo Nir; Maier Lorizate; Aitziber Agirre; Antonio Cruz; Jesús Pérez-Gil; José L Nieva
Journal:  J Biol Chem       Date:  2002-04-02       Impact factor: 5.157

7.  Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization.

Authors:  Mireille Guyader; Etsuko Kiyokawa; Laurence Abrami; Priscilla Turelli; Didier Trono
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Novel properties of cholesterol-dioleoylphosphatidylcholine mixtures.

Authors:  Richard M Epand; Donald W Hughes; Brian G Sayer; Nina Borochov; Diana Bach; Ellen Wachtel
Journal:  Biochim Biophys Acta       Date:  2003-10-13

9.  The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.

Authors:  Nerea Huarte; Maier Lorizate; Rubén Maeso; Renate Kunert; Rocio Arranz; José M Valpuesta; José L Nieva
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

10.  Analysis of accessible surface of residues in proteins.

Authors:  Laurence Lins; Annick Thomas; Robert Brasseur
Journal:  Protein Sci       Date:  2003-07       Impact factor: 6.725

View more
  13 in total

Review 1.  Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design.

Authors:  Lifeng Cai; Miriam Gochin; Keliang Liu
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

2.  Lytic Inactivation of Human Immunodeficiency Virus by Dual Engagement of gp120 and gp41 Domains in the Virus Env Protein Trimer.

Authors:  Bibek Parajuli; Kriti Acharya; Reina Yu; Brendon Ngo; Adel A Rashad; Cameron F Abrams; Irwin M Chaiken
Journal:  Biochemistry       Date:  2016-10-27       Impact factor: 3.162

3.  The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization.

Authors:  Hamid Salimi; Jacklyn Johnson; Manuel G Flores; Michael S Zhang; Yunxia O'Malley; Jon C Houtman; Patrick M Schlievert; Hillel Haim
Journal:  J Biol Chem       Date:  2019-11-22       Impact factor: 5.157

4.  Fusion-competent state induced by a C-terminal HIV-1 fusion peptide in cholesterol-rich membranes.

Authors:  Beatriz Apellániz; José L Nieva
Journal:  Biochim Biophys Acta       Date:  2015-01-21

5.  4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms.

Authors:  Kyle J Nakamura; Johannes S Gach; Laura Jones; Katherine Semrau; Jan Walter; Frederic Bibollet-Ruche; Julie M Decker; Laura Heath; William D Decker; Moses Sinkala; Chipepo Kankasa; Donald Thea; James Mullins; Louise Kuhn; Michael B Zwick; Grace M Aldrovandi
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

6.  Super-Resolution Fluorescence Imaging Reveals That Serine Incorporator Protein 5 Inhibits Human Immunodeficiency Virus Fusion by Disrupting Envelope Glycoprotein Clusters.

Authors:  Yen-Cheng Chen; Chetan Sood; Mariana Marin; Jesse Aaron; Enrico Gratton; Khalid Salaita; Gregory B Melikyan
Journal:  ACS Nano       Date:  2020-06-01       Impact factor: 15.881

7.  Cholesterol Interaction with the MAGUK Protein Family Member, MPP1, via CRAC and CRAC-Like Motifs: An In Silico Docking Analysis.

Authors:  Marcin A Listowski; Jacek Leluk; Sebastian Kraszewski; Aleksander F Sikorski
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

8.  Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model.

Authors:  Orlando DeLeon; Hagit Hodis; Yunxia O'Malley; Jacklyn Johnson; Hamid Salimi; Yinjie Zhai; Elizabeth Winter; Claire Remec; Noah Eichelberger; Brandon Van Cleave; Ramya Puliadi; Robert D Harrington; Jack T Stapleton; Hillel Haim
Journal:  PLoS Biol       Date:  2017-04-06       Impact factor: 8.029

Review 9.  Cholesterol-binding viral proteins in virus entry and morphogenesis.

Authors:  Cornelia Schroeder
Journal:  Subcell Biochem       Date:  2010

10.  Lateral Membrane Heterogeneity Regulates Viral-Induced Membrane Fusion during HIV Entry.

Authors:  Rodion J Molotkovsky; Veronika V Alexandrova; Timur R Galimzyanov; Irene Jiménez-Munguía; Konstantin V Pavlov; Oleg V Batishchev; Sergey A Akimov
Journal:  Int J Mol Sci       Date:  2018-05-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.